Please login to the form below

Not currently logged in
Email:
Password:

Aimovog

This page shows the latest Aimovog news and features for those working in and with pharma, biotech and healthcare.

ICER says price of Amgen/Novartis’ Aimovig is OK - if used last-line

ICER says price of Amgen/Novartis’ Aimovig is OK - if used last-line

Recommends the drug should only be used in patients who have exhausted other prevention options

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Apex.co.uk Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading exhibition stand and event agencies, specialising in healthcare. We understand your communication goals,...

Latest intelligence

Diversity in clinical trials: looking back at our 2021 blogs
In this blog, we look back at the Innovative Trials' Equality & Diversity (E&D) committee blogs across 2021...
What does the future hold for Light-chain Amyloidosis?
Recent advances in the understanding and treatment are reforming pharma’s approach to the management of this rare disease. With a new standard of care rapidly developing, what does the landscape...
Webinar:
Securing a future for telehealth with immersive market research insights...